Correlation Between Scholar Rock and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Scholar Rock and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scholar Rock and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scholar Rock Holding and Inhibrx, you can compare the effects of market volatilities on Scholar Rock and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scholar Rock with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scholar Rock and Inhibrx.
Diversification Opportunities for Scholar Rock and Inhibrx
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Scholar and Inhibrx is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Scholar Rock Holding and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Scholar Rock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scholar Rock Holding are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Scholar Rock i.e., Scholar Rock and Inhibrx go up and down completely randomly.
Pair Corralation between Scholar Rock and Inhibrx
Given the investment horizon of 90 days Scholar Rock Holding is expected to generate 0.99 times more return on investment than Inhibrx. However, Scholar Rock Holding is 1.01 times less risky than Inhibrx. It trades about 0.03 of its potential returns per unit of risk. Inhibrx is currently generating about -0.05 per unit of risk. If you would invest 3,796 in Scholar Rock Holding on December 1, 2024 and sell it today you would earn a total of 86.00 from holding Scholar Rock Holding or generate 2.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Scholar Rock Holding vs. Inhibrx
Performance |
Timeline |
Scholar Rock Holding |
Inhibrx |
Scholar Rock and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scholar Rock and Inhibrx
The main advantage of trading using opposite Scholar Rock and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scholar Rock position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Scholar Rock vs. Revolution Medicines | Scholar Rock vs. Black Diamond Therapeutics | Scholar Rock vs. Passage Bio | Scholar Rock vs. Monte Rosa Therapeutics |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |